Clik here to view.
Quality Electrodynamics (QED) Sells Majority Ownership Interest to Canon Inc.
MAYFIELD VILLAGE, Ohio Quality Electrodynamics, LLC (QED), headquartered in Mayfield Village, Ohio, announced today the sale of 70% of its ownership interest to Canon Inc. (Canon) headquartered in...
View ArticleClik here to view.
Chugai’s Hemlibra Launched for Hemophiia A with Inhibitors in Taiwan
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, launched Hemlibra®, a new drug created by Chugai for routine...
View ArticleClik here to view.
Promethera Biosciences：有关日本业务活动的声明
比利时蒙圣吉贝尔和东京 (美国商业资讯)–2018年5月，细胞药物和肝脏疾病的全球创新者Promethera Biosciences SA (Group)宣布在东京新设分支办事处Promethera Biosciences Japan Branch...
View ArticleClik here to view.
Masimo宣布，用于Root®患者监护和互联平台的Radius Capnography™获得CE标记
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，搭载蓝牙®连接的便携式实时二氧化碳分析仪Radius Capnography™已获得CE标记。Radius Capnography可连接Root®患者监护和互联平台，是适用于各年龄段患者的无缝、无线缆主流二氧化碳分析仪。Radius...
View ArticleClik here to view.
Dr. Reddy’s Q2 & H1 FY20 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter and the half year ended September 30, 2019...
View ArticleClik here to view.
Cook Medical India Opens New Facility in Chennai
CHENNAI, India Cook Medical India celebrated its new office opening. The company has shifted to a modern, 20,000-square foot office at Kochar Jade in Guindy, Chennai. It is located at the city’s...
View ArticleClik here to view.
Octapharma宣布发表fibryga®用于治疗心脏手术患者获得性纤维蛋白原缺乏的数据
瑞士拉亨 (美国商业资讯)–Octapharma宣布发表新的数据，数据显示，纤维蛋白原浓缩物fibryga®是用于心脏手术期间重度出血患者的冷凝蛋白的有效代用品。该数据近期发表于《美国医学会杂志》(JAMA)1。...
View ArticleClik here to view.
Yas Holding Invests in Alvotech and Agrees on a Strategic Partnership for...
REYKJAVIK, Iceland Biopharmaceutical company Alvotech announced today that Abu Dhabi-based investment company, Yas Holding, has acquired a 2.5% stake in their business and signed an agreement for...
View ArticleClik here to view.
Epizyme Establishes Agreements for Up to $270 Million in Funding to Support...
CAMBRIDGE, Mass. Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced funding agreements with Royalty Pharma and its affiliate...
View ArticleClik here to view.
Harbour BioMed Announces Initiation of First-in-human Study of...
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI Harbour BioMed (HBM) today announced the start of the first clinical trial of its next-generation fully human anti-CTLA-4 antibody...
View ArticleClik here to view.
マシモが患者モニタリング&コネクティビティ・プラットフォームRoot®向けRadius Capnography™のCEマーク取得を発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、ブルートゥース無線接続機能を備えた携帯型リアルタイムカプノグラフRadius Capnography™がCEマークを取得したと発表しました。Radius...
View ArticleClik here to view.
Kraig Biocraft Laboratories Completes Rearing of First Production Batch of...
ANN ARBOR, Mich. Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that its operations team at its Vietnamese...
View ArticleClik here to view.
武田公布2019财年第二季度稳健业绩并上调全年利润指引
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TOKYO:4502, NYSE:TAK)： 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20191104006113/zh-CN/ 与2018财年上半年形式营收2...
View ArticleClik here to view.
オクタファルマ、心臓手術を受ける患者での後天的フィブリノゲン欠損症の治療薬としてのfibryga®に関するデータの公表を発表
スイス・ラーヘン （ビジネスワイヤ） — オクタファルマは、フィブリノゲン濃縮製剤fibryga®が、心臓手術中に重度の出血を呈する患者でクリオプレシピテートの有効な代替となることを示す新しいデータが公表されたと発表しました。データは最近、米国医師会誌（JAMA）に掲載されました1。...
View ArticleClik here to view.
Takeda and MD Anderson Announce Collaboration to Accelerate the Development...
HOUSTON & OSAKA, Japan The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced an exclusive license agreement...
View ArticleClik here to view.
Seattle Genetics and BeiGene Announce Global License Agreement for Advanced...
BOTHELL, Wash. & BEIJING & CAMBRIDGE, Mass. Seattle Genetics, Inc. (Nasdaq: SGEN) and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160) today announced that the companies have entered into a license...
View ArticleClik here to view.
Oncternal Therapeutics Announces Interim Clinical Data on TK216 in Ewing...
SAN DIEGO Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that interim data on TK216 –...
View ArticleClik here to view.
Ark Biosciences Reports Successful Completion of Phase II Proof-of-Concept...
SHANGHAI Ark Biosciences, a global biotech company developing innovative therapeutics for viral infection and respiratory diseases, today announced positive topline results of its Phase II...
View ArticleClik here to view.
Samsung Bioepis Enters into Commercialization Agreement for Next-Generation...
INCHEON, Korea Samsung Bioepis Co., Ltd. announced today that it has entered into a new commercialization agreement with Biogen (Nasdaq: BIIB) for two biosimilar candidates under development by...
View ArticleClik here to view.
Promega Enters Global Collaboration with Merck to Develop Microsatellite...
MADISON, Wis. Promega Corporation today announced it has entered into a global collaboration with Merck, known as MSD outside the United States and Canada, to develop Promega’s microsatellite...
View Article